Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Trading Update

17 Jan 2020 07:00

RNS Number : 0947A
Devro PLC
17 January 2020
 

For immediate release 17 January 2020

Devro plc

 

Trading update

 

Devro plc ("Devro" or the "Group"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the year ended 31 December 2019.

 

Full year edible collagen volumes were flat, with the Group delivering overall volume growth of 1% in the second half ("H2"). Slightly lower than anticipated H2 volumes, less favourable country mix combined with a smaller than expected FX benefit due to the strengthening of sterling means we now expect to report underlying operating profit for the year in the range of £39 - £40 million1.

 

Devro continues to execute its growth plans as set out in its "3Cs strategy", defending and building upon its strong market positions in mature markets2 and targeting to increase its share in emerging markets3. After a slower start in the first half of 2019 overall volumes in emerging markets grew 13% in the second half and 7% for the full year. Whilst overall volumes in North America grew 7%, growth during Q4 was not as strong as expected, specifically impacted by a longer than anticipated Christmas shutdown at a key customer. Market conditions in Japan and Europe continued to be challenging as previously guided. In Europe, we saw weak market sentiment, with lower promotional activity due to higher pork prices and the impact of de-stocking by some of our distributor partners, which we expect to continue into H1 2020. As a result, overall sales in mature markets declined 3% in the year.

 

Cost saving initiatives continued to deliver well and we will achieve £7m savings in FY 2019. Leverage at the year-end improved following positive working capital movements and we expect to report covenant net debt / covenant EBITDA of less than 2x as at 31 December 2019.

 

Our proposed plans for the closure of the Bellshill site in Scotland remain on track.

 

In 2020 we expect to achieve strong volume growth in emerging markets. In our mature markets we expect good volume growth in the North American snacking market and, whilst we anticipate a continuation of the challenging market conditions in Europe (particularly in the first half of 2020), we expect overall Group volumes to be ahead of 2019.

 

Devro will announce its results for the year ended 31 December 2019 on 4 March 2020.

 

 

Contacts:

 

Devro plc

Rutger Helbing

Chief Executive Officer

Tel: 020 3865 7637

Jackie Callaway

Chief Financial Officer

 

 

FTI Consulting

Richard Mountain / Nick Hasell

 

Tel: 020 3727 1340

1 Unaudited

2 Devro mature markets include: North America, Continental EU, UK & Ireland, Japan, Australia & NZ

3 Devro emerging markets include: Latin America, Russia & East, Middle East & Africa, South East Asia, China

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFIFUMESSEDF
Date   Source Headline
4th Mar 20147:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2013
24th Feb 20146:09 pmRNSHolding(s) in Company - Amendment
7th Feb 20143:54 pmRNSHolding(s) in Company
27th Jan 201411:06 amRNSHolding(s) in Company
24th Jan 20141:04 pmRNSHolding(s) in Company
31st Dec 201312:36 pmRNSDirector/PDMR Shareholding
28th Nov 20138:29 amRNSDirector/PDMR Shareholding
25th Nov 20132:13 pmRNSBlocklisting Interim Review
14th Nov 20137:00 amRNSInterim Management Statement
15th Oct 20139:28 amRNSNotification of IMS date and Capital Markets Event
27th Sep 20135:26 pmRNSHolding(s) in Company
12th Sep 20134:46 pmRNSDirector/PDMR Shareholding
30th Aug 201311:29 amRNSTotal Voting Rights
12th Aug 20135:12 pmRNSDirector/PDMR Shareholding
31st Jul 20137:00 amRNS2013 Interim Results
30th Jul 20137:00 amRNSAppointment of Non-Executive Director
22nd Jul 201311:21 amRNSBlocklisting Application
5th Jul 201312:57 pmRNSHolding(s) in Company
2nd Jul 201310:00 amRNSInterim Results Webcast Notification
24th Jun 20137:00 amRNSPre-close trading update
18th Jun 20134:27 pmRNSHolding(s) in Company
14th Jun 20139:30 amRNSNotification of Upcoming Updates
31st May 20135:00 pmRNSTotal Voting Rights
24th May 20135:00 pmRNSBlocklisting Six Monthly Return
13th May 20133:17 pmRNSDirector/PDMR Transaction
3rd May 20133:36 pmRNSDirector/PDMR Transaction
30th Apr 201312:47 pmRNSTotal Voting Rights
23rd Apr 20134:43 pmRNSDirectors Dealings
23rd Apr 20139:24 amRNSHolding(s) in Company
23rd Apr 20137:00 amRNSSite Visit
22nd Apr 201310:34 amRNSHolding(s) in Company
18th Apr 20135:21 pmRNSResults of Annual General Meeting
18th Apr 20137:00 amRNSIMS & AGM
11th Apr 20133:32 pmRNSHolding(s) in Company
5th Apr 20133:10 pmRNSBlocklisting Application
2nd Apr 20138:06 amRNSTotal Voting Rights
28th Mar 20132:43 pmRNSHolding(s) in Company
22nd Mar 20134:35 pmRNSHolding(s) in Company
19th Mar 20134:33 pmRNSDirector/PDMR Shareholding
15th Mar 20132:00 pmRNS2012 Annual Report
14th Mar 20135:10 pmRNSDirector/PDMR Shareholding
1st Mar 20133:48 pmRNSDirector/PDMR Shareholding
26th Feb 201311:44 amRNS2012 Final Dividend Record Date Amendment
26th Feb 20137:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2012
14th Jan 201312:29 pmRNSListing Rule 9.6.14(R) Disclosure
8th Jan 20132:25 pmRNSPreliminary Results Notification
21st Dec 20122:22 pmRNSAnnual Information Update
19th Dec 20125:31 pmRNSDirector/PDMR Shareholding
18th Dec 20128:59 amRNSListing Rule 9.6.14(R) Disclosure
23rd Nov 20128:53 amRNSBlocklisting Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.